What is the recommended dose of cefdinir (Cefdinir) for a pediatric patient weighing 33 kg with a urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pediatric Dosing of Cefdinir for UTI in a 33 kg Child

For a 33 kg pediatric patient with a urinary tract infection, the recommended dose of cefdinir is 14 mg/kg/day divided into one or two daily doses, which equals approximately 462 mg/day (either as 231 mg twice daily or 462 mg once daily) for 7-14 days. 1

Dosing Considerations

  • Cefdinir is an oral third-generation cephalosporin with good activity against common urinary tract pathogens 1
  • For pediatric patients, the standard dosing is 14 mg/kg/day, which can be administered as:
    • Once-daily dosing: 14 mg/kg once daily (462 mg for a 33 kg child)
    • Twice-daily dosing: 7 mg/kg twice daily (231 mg twice daily for a 33 kg child) 1

Duration of Therapy

  • The recommended duration for treating UTIs in pediatric patients is 7-14 days 2
  • Shorter courses (1-3 days) have been shown to be inferior for febrile UTIs 2

Efficacy for UTIs

  • Cefdinir has demonstrated 95.6% susceptibility against common urinary pathogens in pediatric patients, including Escherichia coli, Klebsiella spp, and Proteus spp 3
  • This susceptibility rate is comparable or superior to many other commonly used antibiotics for UTIs:
    • Ampicillin (49.4%)
    • Trimethoprim-sulfamethoxazole (84.9%)
    • Cefazolin (88.4%)
    • Nitrofurantoin (93.3%)
    • Ticarcillin-clavulanate (94.2%)
    • Gentamicin (97.5%)
    • Ceftriaxone (97.7%) 3

Alternative Options for UTIs in Pediatric Patients

If cefdinir is unavailable or contraindicated, other empiric oral options include:

  • Amoxicillin-clavulanate: 20-40 mg/kg/day divided into 3 doses 2
  • Cefixime: 8 mg/kg/day as a single dose 2
  • Cefpodoxime: 10 mg/kg/day divided into 2 doses 2
  • Cefprozil: 30 mg/kg/day divided into 2 doses 2
  • Cephalexin: 50-100 mg/kg/day divided into 4 doses 2

Important Clinical Considerations

  • Cefdinir has shown good distribution in tissues and fluids, with a pharmacokinetic profile allowing once or twice daily administration 1
  • The oral suspension formulation has demonstrated superior palatability compared to other oral antimicrobial agents, which may improve adherence in pediatric patients 1
  • For patients who appear toxic or unable to tolerate oral medications, consider initial parenteral therapy until clinical improvement occurs (typically within 24-48 hours) 2
  • Local antimicrobial sensitivity patterns should guide empiric therapy choices, with adjustment based on culture results when available 2

Potential Adverse Effects

  • The most common side effects observed with cefdinir in pediatric patients are gastrointestinal, including diarrhea and loose stools (reported in approximately 12.5% of cases) 4, 5
  • These side effects are generally mild and rarely require discontinuation of therapy 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Susceptibility of recent bacterial isolates to cefdinir and selected antibiotics among children with urinary tract infections.

Academic emergency medicine : official journal of the Society for Academic Emergency Medicine, 2006

Research

[Clinical evaluation of cefdinir 10% granules in children].

The Japanese journal of antibiotics, 1991

Research

[Clinical evaluation of cefdinir 5% fine granules in pediatrics].

The Japanese journal of antibiotics, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.